Clinical Importance of Cannabinoid Type 1 Receptor (CB1R) and Cannabinoid Type 2 Receptor (CB2R) Expression in Renal Cell Carcinoma
Dimitrios Deligiannis1, Ioannis Anastasiou2, Dionysios Mitropoulos2
1Department of Urology, Naval Hospital of Athens, Athens, GRC.
Related Experiment Videos

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
View abstract on PubMed
Cannabinoid type 2 receptor (CB2R) is highly expressed in most renal cell carcinomas (RCCs), unlike cannabinoid type 1 receptor (CB1R). Enhanced CB2R expression correlates with specific clinicopathological aspects, suggesting its potential as a prognostic marker or therapeutic target in RCC.
Area of Science:
- Oncology
- Molecular Biology
- Immunohistochemistry
Background:
- Cannabinoid receptors, specifically CB1R and CB2R, play roles in various physiological processes.
- Their expression and function in renal cell carcinoma (RCC) are not fully understood.
- Investigating these receptors may reveal new insights into RCC pathogenesis and treatment.
Purpose of the Study:
- To evaluate the expression of CB1R and CB2R in RCC tissues.
- To correlate receptor expression with clinicopathological features of RCC patients.
- To explore the potential of CB1R and CB2R as biomarkers or therapeutic targets in RCC.
Main Methods:
- Retrospective analysis of 87 RCC patient specimens.
- Immunohistochemical assessment of CB1R and CB2R expression (positivity, intensity, percentage, distribution, score).
- Statistical analysis including unifactorial and multifactorial correlations with clinicopathological parameters.
Main Results:
- CB1R was not expressed in any RCC samples.
- CB2R was highly expressed in 89.7% of RCC patients.
- Multifactorial analysis revealed associations between CB2R expression and papillary/clear-cell histology, T2 stage, male gender, and chromophobe histology.
Conclusions:
- CB1R is absent in RCC, while CB2R is ubiquitously expressed.
- Enhanced CB2R expression correlates with specific clinicopathological characteristics in RCC.
- CB2R holds promise as a potential prognostic marker and therapeutic target for RCC.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...